Heping Xu

414 total citations
29 papers, 225 citations indexed

About

Heping Xu is a scholar working on Epidemiology, Infectious Diseases and Nephrology. According to data from OpenAlex, Heping Xu has authored 29 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 7 papers in Infectious Diseases and 5 papers in Nephrology. Recurrent topics in Heping Xu's work include Sepsis Diagnosis and Treatment (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Antifungal resistance and susceptibility (4 papers). Heping Xu is often cited by papers focused on Sepsis Diagnosis and Treatment (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Antifungal resistance and susceptibility (4 papers). Heping Xu collaborates with scholars based in China, Australia and Netherlands. Heping Xu's co-authors include Li‐Ying Sun, Chen Li, Xingchun Chen, Binghuai Lu, Lei Huang, Lili Xiang, Jinjian Yao, Xiaobo Ma, Huan Niu and Xiang Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Medicine.

In The Last Decade

Heping Xu

27 papers receiving 225 citations

Peers

Heping Xu
A Ondrusova Slovakia
Stephen Hood United Kingdom
Carleton M. Sherman United States
Dereje A. Negatu United States
Heping Xu
Citations per year, relative to Heping Xu Heping Xu (= 1×) peers Yoji Nagasaki

Countries citing papers authored by Heping Xu

Since Specialization
Citations

This map shows the geographic impact of Heping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heping Xu more than expected).

Fields of papers citing papers by Heping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heping Xu. The network helps show where Heping Xu may publish in the future.

Co-authorship network of co-authors of Heping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Heping Xu. A scholar is included among the top collaborators of Heping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heping Xu. Heping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Heping, et al.. (2025). Association of TyG index with mortality at 28 days in sepsis patients in intensive care from MIMIC IV database. Scientific Reports. 15(1). 2344–2344. 5 indexed citations
2.
Xu, Heping, et al.. (2025). Associations between triglyceride-glucose body mass index and all-cause mortality in ICU patients with sepsis and acute heart failure. BMC Cardiovascular Disorders. 25(1). 359–359. 1 indexed citations
4.
5.
Xu, Heping, et al.. (2024). Knockdown of RTEL1 Alleviates Chronic Obstructive Pulmonary Disease by Modulating M1, M2 Macrophage Polarization and Inflammation. COPD Journal of Chronic Obstructive Pulmonary Disease. 21(1). 2316607–2316607. 6 indexed citations
7.
Xu, Heping, et al.. (2024). Identification of blaKPC-90 in Klebsiella pneumoniae associated with ceftazidime-avibactam resistance and the translocation & truncation of resistant genes mediated by IS26. International Journal of Antimicrobial Agents. 65(1). 107388–107388. 2 indexed citations
8.
9.
Zhu, Xinlin, Cong Yang, Qing Hou, et al.. (2022). Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China. Mycoses. 65(12). 1159–1169. 7 indexed citations
10.
Ma, Xiaobo, et al.. (2022). MALDI-TOF MS-Based Clustering and Antifungal Susceptibility Tests of Talaromyces marneffei Isolates from Fujian and Guangxi (China). Infection and Drug Resistance. Volume 15. 3449–3457. 14 indexed citations
11.
Huang, Yulan, et al.. (2022). Emergence of a Salmonella Rissen ST469 clinical isolate carrying blaNDM-13 in China. Frontiers in Cellular and Infection Microbiology. 12. 936649–936649. 10 indexed citations
12.
Li, Jun, et al.. (2022). Acute Post-Cataract Endophthalmitis Due to Phialemoniopsis curvata: A Rare Case Report. Infection and Drug Resistance. Volume 15. 1651–1657.
13.
Wang, Xiaofeng, et al.. (2021). The evolution of social space in mountainous rural areas: A case study of three counties in Qinling Mountains area, Shaanxi. 自然资源学报. 36(10). 2557–2557. 1 indexed citations
14.
Bing, Jian, et al.. (2021). A case of Candida auris candidemia in Xiamen, China, and a comparative analysis of clinical isolates in China. Mycology: An International Journal on Fungal Biology. 13(1). 68–75. 18 indexed citations
15.
Fang, Lili, Heping Xu, Xun Li, et al.. (2020). Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study. Frontiers in Cellular and Infection Microbiology. 10. 462–462. 12 indexed citations
16.
Huang, Lei, Xingchun Chen, Heping Xu, et al.. (2018). Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009–2017. Diagnostic Microbiology and Infectious Disease. 94(2). 165–172. 59 indexed citations
17.
Ding, Yipeng, et al.. (2017). Association between <em>RTEL1</em> gene polymorphisms and COPD susceptibility in a Chinese Han population. International Journal of COPD. Volume 12. 931–936. 6 indexed citations
18.
Ding, Yipeng, Ping He, Na He, et al.. (2016). Genetic polymorphisms of pharmacogenomic VIP variants in Li nationality of southern China. Environmental Toxicology and Pharmacology. 42. 237–242. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026